ATH 25.0% 0.5¢ alterity therapeutics limited

"As requested by the FDA, our ‘Complete Response’ includes our...

  1. 2,713 Posts.
    lightbulb Created with Sketch. 941
    "As requested by the FDA, our ‘Complete Response’ includes our proposed Phase 3 protocol for testing the cognitive efficacy, safety and tolerability of PBT2 in patients with Huntington disease (HD). Our Complete Response has been lodged and we await the response from the FDA".
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $27.94K 6.050M

Buyers (Bids)

No. Vol. Price($)
46 57663299 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 56205001 43
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 20524121
Last updated 15.46pm 29/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.